NEW YORK, Sept 28 –German bioinformatics company Lion Bioscience (Neuer Markt: LIO, Nasdaq: LEON) said Thursday its first quarter fiscal 2001 net losses increased to 14.04 million euros ($12.4 million), or 1.84 euros per share, compared with net losses of 3.31 million euros, or 0.60 euro a share, in the year ago period.

The first-quarter 2001 results include a non-cash compensation expense of 8.7 million euros from the conversion of preferred shares to ordinary shares.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.